These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23996162)

  • 41. Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer.
    Sasaki K; Onodera S; Otsuka K; Satomura H; Kurayama E; Kubo T; Takahashi M; Ito J; Nakajima M; Yamaguchi S; Miyachi K; Kato H
    Med Oncol; 2017 Aug; 34(8):139. PubMed ID: 28707042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of interim 18F-FDG PET/CT in predicting early response to neoadjuvant chemotherapy in breast cancer.
    Pahk K; Rhee S; Cho J; Seo M; Lee S; Park T; Park S; Lee E; Park KH; Kim C; Eo JS; Kim S; Choe JG
    Anticancer Res; 2014 Aug; 34(8):4447-55. PubMed ID: 25075084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neoadjuvant radiochemotherapy in locally advanced gastric carcinoma.
    Klautke G; Foitzik T; Ludwig K; Ketterer P; Klar E; Fietkau R
    Strahlenther Onkol; 2004 Nov; 180(11):695-700. PubMed ID: 15549187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Locally advanced gastric cancer: total iodine uptake to predict the response of primary lesion to neoadjuvant chemotherapy.
    Gao X; Zhang Y; Yuan F; Ding B; Ma Q; Yang W; Yan J; Du L; Wang B; Yan F; Sedlmair M; Pan Z; Zhang H
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2207-2218. PubMed ID: 30094537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intra-tumor metabolic heterogeneity of gastric cancer on
    Liu G; Yin H; Cheng X; Wang Y; Hu Y; Liu T; Shi H
    Clin Exp Med; 2021 Feb; 21(1):129-138. PubMed ID: 32880779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Computed tomography (CT) perfusion as an early predictive marker for treatment response to neoadjuvant chemotherapy in gastroesophageal junction cancer and gastric cancer--a prospective study.
    Lundsgaard Hansen M; Fallentin E; Lauridsen C; Law I; Federspiel B; Bæksgaard L; Svendsen LB; Nielsen MB
    PLoS One; 2014; 9(5):e97605. PubMed ID: 24845062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Computed tomography response, but not positron emission tomography scan response, predicts survival after neoadjuvant chemotherapy for resectable non-small-cell lung cancer.
    Tanvetyanon T; Eikman EA; Sommers E; Robinson L; Boulware D; Bepler G
    J Clin Oncol; 2008 Oct; 26(28):4610-6. PubMed ID: 18824709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Six months neoadjuvant imatinib improves resectability potential of gastric stromal tumors in Egyptian patients.
    Saied GM; Kensarah AM
    Int J Surg; 2010; 8(2):105-8. PubMed ID: 19944196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer.
    Lee SM; Kim SH; Lee JM; Im SA; Bang YJ; Kim WH; Kim MA; Yang HK; Lee HJ; Kang WJ; Han JK; Choi BI
    Abdom Imaging; 2009 Jul; 34(4):430-40. PubMed ID: 18546037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT.
    Mikhaeel NG; Timothy AR; O'Doherty MJ; Hain S; Maisey MN
    Leuk Lymphoma; 2000 Nov; 39(5-6):543-53. PubMed ID: 11342337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer.
    Groheux D; Sanna A; Majdoub M; de Cremoux P; Giacchetti S; Teixeira L; Espié M; Merlet P; de Roquancourt A; Visvikis D; Hatt M; Resche-Rigon M; Hindié E
    J Nucl Med; 2015 Jun; 56(6):824-31. PubMed ID: 25883123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer.
    Migita K; Nashimoto A; Yabusaki H; Matsuki A; Aizawa M
    Int J Clin Oncol; 2016 Feb; 21(1):102-9. PubMed ID: 26017926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Staging of adenocarcinoma of the gastroesophageal junction.
    Parry K; Haverkamp L; Bruijnen RC; Siersema PD; Offerhaus GJ; Ruurda JP; van Hillegersberg R
    Eur J Surg Oncol; 2016 Mar; 42(3):400-6. PubMed ID: 26777127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI.
    Cheung YC; Chen SC; Su MY; See LC; Hsueh S; Chang HK; Lin YC; Tsai CS
    Breast Cancer Res Treat; 2003 Mar; 78(1):51-8. PubMed ID: 12611457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
    Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A
    Oncology; 2004; 67(1):48-53. PubMed ID: 15459495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multimodal imaging of esophagus and cardia cancer before and after treatment.
    Fiore D; Baggio V; Ruol A; Bocus P; Casara D; Corti L; Muzzio PC
    Radiol Med; 2006 Sep; 111(6):804-17. PubMed ID: 16896560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
    Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ
    Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Is neoadjuvant therapy for locally advanced stomach carcinoma standard?].
    Ajani JA
    Chirurg; 2002 Apr; 73(4):312-5. PubMed ID: 12063914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Can low-dose CT perfusion imaging accurately assess response of advanced gastric cancer with neoadjuvant chemotherapy?
    Sun ZQ; Yan G; Ge YX; Li J; Jin LF; Xie ZH; Zhao P
    J Xray Sci Technol; 2017; 25(6):981-991. PubMed ID: 28697579
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A large series, resection controlled study to assess the value of radial EUS in restaging gastroesophageal cancer following neoadjuvant chemotherapy.
    Mesenas S; Vu C; McStay M; Forshaw M; Doig L; Mason R; Boyle N; Meenan J
    Dis Esophagus; 2008; 21(1):37-42. PubMed ID: 18197937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.